IMU 1.89% 5.2¢ imugene limited

Ann: Imugene onCARlytics Doses First Patient in IV Combination, page-90

  1. 153 Posts.
    lightbulb Created with Sketch. 487
    Why would they not?

    The one thing the company seems to constantly announce is first patient dosed in trial.

    In direct answer to your question regarding expansions.
    Did they announced the phase 1B trial expansion for Azercel first patient dosed this year?

    Yes they did.

    I don't see why MAST bile duct expansion would be treated any different. Those 10 patients will make their own specific data set as will the Azercel expansion.


 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.